News

Be Biopharma, Inc. (“Be Bio”) and National Resilience, Inc. (Resilience) announced a strategic collaboration to advance initial programs in Be Bio’s rare disease pipeline. Be Bio’s…
Read More...

Atara Biotherapeutics, Inc. a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and…
Read More...

AbbVie announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor…
Read More...

Eli Lilly and Company and Incyte announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for OLUMIANT …
Read More...

Sinclair Pharma, a global pharmaceutical brand providing aesthetic dermatology and collagen solutions is collaborating exclusively with Vanguard Aesthetics to bring the Silhouette Soft…
Read More...

Ascentage Pharma, a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that a new…
Read More...

Laekna Therapeutics, a clinical-stage global biotechnology company dedicated to developing next generation medicines to treat cancer and liver diseases, announced that it has raised $61…
Read More...

Tonix Pharmaceuticals Holding Corp. announced it has entered into a license agreement and extended a research collaboration with the University of Alberta, a leading Canadian research…
Read More...

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, announced a multi-year collaboration with the National Institutes of Health to develop…
Read More...

SwanBio Therapeutics, a gene therapy company advancing adeno-associated virus (AAV)-based therapies for the treatment of devastating, inherited neurological conditions, today announced…
Read More...

AstraZeneca has entered into a licence agreement with RQ Biotechnology Ltd (RQ Bio) for a portfolio of early-stage monoclonal antibodies (mAbs) targeted against SARS-CoV-2, the virus…
Read More...

Pfizer Inc. and BioNTech SE announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization (EUA) to include a booster dose after completion of the primary…
Read More...

Sernova Corp. a clinical-stage company and leader in regenerative medicine cell therapeutics, and Evotec SE a global pharmaceutical and life science company, and leading developer of…
Read More...

Zealand Pharma A/S a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced it has entered into an asset purchase agreement with…
Read More...

Proscia, a leader in digital and computational pathology solutions, has introduced an automated quality control application that leverages artificial intelligence to improve quality and…
Read More...

SIMCERE PHARMA announced that SIM0417, a candidate drug against SARS-Cov-2, for which the Company holds license from Shanghai Institute of Materia Medica (SIMM) and Wuhan Institute of…
Read More...

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer Genomics.…
Read More...

Proteros biostructures GmbH (“Proteros”), an expert in integrated structure-based drug discovery, announces an expansion of its collaboration with AstraZeneca focused on the discovery…
Read More...

Kriya Therapeutics, Inc., a fully integrated gene therapy company pioneering novel technologies and therapeutics, announced a $270 Million Series C financing. The financing was led by…
Read More...

AbbVie and Cugene Inc., a clinical-stage biotechnology company focused on developing next-generation precision immunology and oncology medicines to treat autoimmune disease and cancer,…
Read More...